Combined Sono-electro-magnetic Therapy for Treatment of Refractory Chronic Pelvic Pain Syndrome
CompletedNot applicableNCT00688506
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Treatment of chronic pelvic pain syndrome (CPPS) is challenging for patients and physicians once conventional therapies fail. We hypothesize that combined sono-electro-magnetic therapy can improve refractory CPPS in men. In addition, we postulate that combined sono-electro-magnetic therapy as well as placebo therapy has a significant effect on brain activity detectable by functional MRI.
Study details
- Official title
- Combined Sono-electro-magnetic Therapy for Treatment of Refractory Chronic Pelvic Pain Syndrome: A Prospective, Randomized, Double-blind, Placebo-controlled Trial
- Conditions
- Interventions
- Device: combined sono-electro-magnetic therapy (Sonodyn Medico Star)
- Device: placebo therapy (Placebo Sonodyn Medico Star)
- Sponsor
- Insel Gruppe AG, University Hospital Bern
- Start date
- 2009-11
- Primary completion
- 2012-07
- Sex
- Male
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Switzerland
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * CPSS III * symptomatic \>3 months * NIH-CPSI total score =/\>15 * NIH-CPSI pain =/\>8 Exclusion Criteria: * post void residual \>100mL * urinary tract infection * urethral stricture * prostate cancer * age \<18 years * claustrophobia * pacemaker, neurostimulator, insulin / pain pump
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT00688506